RxDoctor Payments Data

Ricky Brockington

Nurse Practitioner · Franklin, VANPI 1871108233

Payments from drug & device makers

$487in general payments, 2019–2025

Across 31 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$244
  • Lilly USA, LLC$57
  • AstraZeneca$56
  • Pfizer$27
  • Inspire Medical Systems, Inc.$26
  • AbbVie$23
  • plus $55 from 4 others

What the payments were for

  • Food & beverage$487100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$487 in reported general payments places this provider in the 75th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$127,727
Medicare patients
391
Services billed
1,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin79$113,148
EliquisApixaban86$107,235
JanuviaSitagliptin Phosphate64$79,846
TrulicityDulaglutide33$48,831
OzempicSemaglutide29$47,117
JanumetSitagliptin Phos/Metformin Hcl21$24,462
XareltoRivaroxaban17$21,308
LinzessLinaclotide22$20,111
Breo ElliptaFluticasone/Vilanterol35$16,469
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,475
FarxigaDapagliflozin Propanediol15$12,177
Lantus SolostarInsulin Glargine,hum.Rec.Anlog66$8,264
EntrestoSacubitril/Valsartan11$8,128
SymbicortBudesonide/Formoterol Fumarate11$6,074
Atorvastatin Calcium674$6,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Dulera$12$109,12098 claims
PfizerEliquis$27$107,23586 claims
Novo NordiskOzempic, Levemir$244$50,12340 claims
Lilly USA, LLCTrulicity$57$48,83133 claims
AbbVieLinzess$23$20,11122 claims
AstraZenecaFarxiga, Symbicort$56$18,25026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Franklin

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →